Abstract: Provided are a method for separating mammalian sperm, by which even a large amount of sperm can be separated in a short time and decrease in motility of the separated sperm can be prevented; and an artificial insemination method, and an in vitro fertilization method. The method for separating mammalian sperm includes incubating the sperm in a medium containing a TLR7 ligand, and separating them into sperm floating in the upper layer and sperm sinking in the lower layer of the medium. The artificial insemination and in vitro fertilization methods include artificial insemination or in vitro fertilization for a non-human mammal using sperm of the non-human mammal separated by the method for separating mammalian sperm.

Abstract: An electromagnetic induction heating apparatus comprises: a resonance circuit that includes a inductor and a capacitor; a direct-current electric power supply; and a switching element performing ON and OFF switching of electric power supplied to the resonance circuit by the direct-current electric power supply; performs intermittent control of the electric power supply by controlling the ON and OFF switching at regular intervals, and by performing control to stop the electric power supply when not controlling the ON and OFF switching, wherein during the intermittent control, the switching control unit performs gradual control such that, upon beginning the control of the ON and OFF switching, the electric power supply gradually increases to reach a target value, and upon stopping the control of the ON and OFF switching, the electric power supply gradually decreases from the target value until stopping, such that the gradual decrease involves fewer steps than the gradual increase.

Abstract: An electromagnetic induction heating apparatus comprises: a resonance circuit that includes a inductor and a capacitor; a direct-current electric power supply; and a switching element performing ON and OFF switching of electric power supplied to the resonance circuit by the direct-current electric power supply; performs intermittent control of the electric power supply by controlling the ON and OFF switching at regular intervals, and by performing control to stop the electric power supply when not controlling the ON and OFF switching, wherein during the intermittent control, the switching control unit performs gradual control such that, upon beginning the control of the ON and OFF switching, the electric power supply gradually increases to reach a target value, and upon stopping the control of the ON and OFF switching, the electric power supply gradually decreases from the target value until stopping, such that the gradual decrease involves fewer steps than the gradual increase.

Abstract: Novel proteins and polypeptides binding to osteoclastogenesis inhibitory factor (OCIF) (OCIF-binding molecules, OBMs) and nucleic acids encoding these proteins and polypeptides are provided. Processes for producing these proteins, polypeptides, and nucleic acid molecules by genetic engineering are provided. Medicinal compounds are provided which comprise proteins and nucleic acids according to the invention, as well as proteins which bind to OBM, including anti-OBM antibodies. These compounds may be used for the treatment of bone disease.

Abstract: There is described a paper sheet conveyance apparatus, which makes it possible to surely separate the overlapping paper sheets from each other irrespective of a kind of paper. The apparatus includes: a thickness detecting section to detect a thickness of a paper sheet, currently conveyed in the conveyance path; a first suction device to adsorb the conveyance paper sheet currently passing through the first suction device; a second suction device to adsorb the overlap paper sheet currently passing through the second suction device; an overlapping conveyance path that is branched from the conveyance path; and a control section that activates the first suction device and the second suction device so as to separate the conveyance paper sheet from the overlap paper sheet, and to introduce the conveyance paper sheet and the overlap paper sheet into the conveyance path and the overlapping conveyance path, respectively.

Abstract: A tandem type color image forming apparatus which executes color misregistration correction, including: a detecting section which detects a width of a transfer sheet; an image forming section having an image carrier, on which arranged side by side are an image area where formed is an image for transfer and a non-image area where formed is an imprint image; and a control section which selects a complex or a single correction mode based on the transfer sheet width, to execute correction processing; where the complex correction mode is an operation mode of forming in parallel the image for transfer in the image area and the imprint image in the non-image area, and the single correction mode is an operation mode of suspending to form the image for transfer in the image area, and executing only to form the imprint image in the non-image area or in the image area.

Abstract: Novel proteins and polypeptides binding to osteoclastogenesis inhibitory factor (OCIF) (OCIF-binding molecules, OBMs) and nucleic acids encoding these proteins and polypeptides are provided. Processes for producing these proteins, polypeptides, and nucleic acid molecules by genetic engineering are provided. Medicinal compounds are provided which comprise proteins and nucleic acids according to the invention, as well as proteins which bind to OBM, including anti-OBM antibodies. These compounds may be used for the treatment of bone disease.

Abstract: There are provided a field data display apparatus capable of flexibly coping with field data elements differing in collection period from each other, and a method for displaying the field data. A trend data collection server collects field data elements from control stations, in predetermined periods, respectively, to be stored as trend data elements corresponding to tag names, respectively, in a trend data storage. A display unit displays selected trend data elements selected by a selective operation acceptance unit on a display screen. The selective operation acceptance unit accepts an operation for selecting trend data elements, the trend data elements each having a plurality of collection periods differing from each other, mixedly present in the collection period of the field data element.

Abstract: Novel proteins and polypeptides binding to osteoclastogenesis inhibitory factor (OCIF) (OCIF-binding molecules, OBMs) and nucleic acids encoding these proteins and polypeptides are provided. Processes for producing these proteins, polypeptides, and nucleic acid molecules by genetic engineering are provided. Medicinal compounds are provided which comprise proteins and nucleic acids according to the invention, as well as proteins which bind to OBM, including anti-OBM antibodies. These compounds may be used for the treatment of bone disease.

Abstract: An image forming apparatus provided with an image forming section and a fixing section, comprising: a memory section which stores relationships between a plurality of instruction forms of image formation and a plurality of power supply methods including a power supply by both an AC power source and a capacitor to the fixing section and a power supply only by the AC power source to the fixing section; and a controller, when receiving an instruction of image formation, that refers to the memory section on a basis of an instruction form of the received instruction of image formation and supplies power by both the AC power source and capacitor to the fixing section, or supplies power only by the AC power source to the fixing section.

Abstract: A protein which inhibits osteoclast differentiation and/or maturation and a method for producing the protein. The protein is produced by human embryonic lung fibroblasts and has a molecular weight of about 60 kD and about 120 kD under non-reducing conditions and about 60 kD under reducing conditions on SDS-polyacrylamide gel electrophoresis. The protein can be isolated and purified from the culture medium of fibroblasts. Furthermore, the protein can be produced by gene engineering. The present invention includes cDNA for producing the protein by gene engineering, antibodies having specific affinity for the protein or a method for determining protein concentration using these antibodies.

Abstract: The present invention relates to a novel protein which binds to Osteoclastogenesis Inhibitory Factor (OCIF-binding molecule; OBM), a process for preparing the same, DNA encoding said protein, a protein having an amino acid sequence encoded by this DNA, a method for producing said protein by genetic engineering technique, and a pharmaceutical composition containing said protein. In addition, screening methods for a substance for controlling expression of said protein using said protein and the DNA, a substance which inhibits or modulates the biological activity of said protein, or a receptor which transmits the action of said protein through binding to said protein, the substance obtained by the screening methods, and a pharmaceutical composition which contains this substance are disclosed. An antibody for said protein, a process for preparing the same, a measuring method of said protein using the antibody, and a medicine comprising the antibody are also disclosed.

Abstract: A novel protein which binds to Osteoclastogenesis Inhibitory Factor (OCIF-binding molecule; OBM), a process for preparing the same, DNA encoding said protein, a protein having an amino acid sequence encoded by this DNA, a method for producing said protein by genetic engineering technique, and a pharmaceutical composition containing said protein. Screening methods for a substance for controlling expression of said protein using said protein and the DNA, a substance which inhibits or modulates the biological activity of said protein, or a receptor which transmits the action of said protein through binding to said protein, the substance obtained by the screening methods, and a pharmaceutical composition which contains this substance. An antibody for said protein, a process for preparing the same, a measuring method of said protein using the antibody, and a medicine comprising this antibody.

Abstract: A tandem type color image forming apparatus which executes color misregistration correction, including: a detecting section which detects a width of a transfer sheet; an image forming section having an image carrier, on which arranged side by side are an image area where formed is an image for transfer and a non-image area where formed is the imprint image; and a control section which selects a complex or a single correction mode based on the transfer sheet width, to execute correction processing; where the complex correction mode is an operation mode of forming in parallel the image for transfer in the image area and the imprint image in the non-image area, and the single correction mode is an operation mode of suspending to form the image for transfer in the image area, and executing only to form the imprint image in the non-image area or in the image area.

Abstract: A protein which inhibits osteoclast differentiation and/or maturation and a method of production of the protein. The protein is produced by human embryonic lung fibroblasts and has molecular weight of about 60 kD and about 120 kD under non-reducing conditions and about 60 kD under reducing conditions on SDS-polyacrylamide gel electrophoresis, respectively. The protein can be isolated and purified from culture medium of the said fibroblasts. Furthermore, the protein can be produced by gene engineering. The present invention includes cDNA for producing the protein by gene engineering, antibodies having specific affinity to the protein or a method for determination of the protein concentration using the antibodies.

Abstract: There is described a paper sheet conveyance apparatus, which makes it possible to surely separate the overlapping paper sheets from each other irrespective of a kind of paper. The apparatus includes: a thickness detecting section to detect a thickness of a paper sheet, currently conveyed in the conveyance path; a first suction device to adsorb the conveyance paper sheet currently passing through the first suction device; a second suction device to adsorb the overlap paper sheet currently passing through the second suction device; an overlapping conveyance path that is branched from the conveyance path; and a control section that activates the first suction device and the second suction device so as to separate the conveyance paper sheet from the overlap paper sheet, and to introduce the conveyance paper sheet and the overlap paper sheet into the conveyance path and the overlapping conveyance path, respectively.

Abstract: A novel protein and a process of producing the protein is provided. The protein is a glycoprotein having activity of suppressing the differentiation and/or maturation of adipocyte, having a molecular weight of about 45 kD under non-reducing conditions and about 28 kD and/or 23 kD under reducing conditions, and exhibiting affinity to heparin. A process of producing the protein comprising culturing human fibroblasts and purifying the culture broth by chromatography using an ion exchange column, affinity column, and reverse phase column. A cDNA encoding the protein and a process of producing the protein using the cDNA are also provided. The protein of the present invention is useful as a pharmaceutical composition for preventing or treating obesity or as an antigen for establishing immunological diagnosis, etc.

Abstract: A protein which inhibits osteoclast differentiation and/or maturation and a method for producing the protein. The protein is produced by human embryonic lung fibroblasts and has a molecular weight of about 60 kD and about 120 kD under non-reducing conditions and about 60 kD under reducing conditions on SDS-polyacrylamide gel electrophoresis. The protein can be isolated and purified from the culture medium of fibroblasts. Furthermore, the protein can be produced by gene engineering. The present invention includes cDNA for producing the protein by gene engineering, antibodies having specific affinity for the protein or a method for determining protein concentration using these antibodies.